1,2-dipalmitoylphosphatidylcholine has been researched along with pyrazinamide in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fattal, E; Ghermani, N; Guiblin, N; Pham, DD; Tsapis, N | 1 |
Das, SC; Eedara, BB; Tucker, IG | 1 |
Cavallaro, A; Das, SC; Doyle, C; Eedara, BB; Rangnekar, B | 1 |
3 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and pyrazinamide
Article | Year |
---|---|
Formulation of pyrazinamide-loaded large porous particles for the pulmonary route: avoiding crystal growth using excipients.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Administration, Inhalation; Antitubercular Agents; Bicarbonates; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Crystallization; Excipients; Hyaluronic Acid; Leucine; Particle Size; Porosity; Powder Diffraction; Pyrazinamide; X-Ray Diffraction | 2013 |
Phospholipid-based pyrazinamide spray-dried inhalable powders for treating tuberculosis.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Administration, Inhalation; Aerosols; Antitubercular Agents; Chemistry, Pharmaceutical; Desiccation; Drug Delivery Systems; Dry Powder Inhalers; Excipients; Leucine; Lung; Nanoparticles; Particle Size; Phosphatidylethanolamines; Phospholipids; Polyethylene Glycols; Powders; Pyrazinamide; Tuberculosis | 2016 |
The influence of surface active l-leucine and 1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine (DPPC) in the improvement of aerosolization of pyrazinamide and moxifloxacin co-spray dried powders.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Aerosols; Antitubercular Agents; Chemistry, Pharmaceutical; Desiccation; Excipients; Fluoroquinolones; Leucine; Moxifloxacin; Particle Size; Powders; Pyrazinamide | 2018 |